![](/img/cover-not-exists.png)
[4] EZETIMIBE/SIMVASTATIN COMPARED WITH DOUBLING THE DOSE OF SIMVASTATIN IN HIGH CARDIOVASCULAR RISK PATIENTS NOT AT LDL-C TARGET WITH SIMVASTATIN ALONE: THE DIALOGUE STUDY
M. Averna, A. Zaninelli, C. Le Grazie, G.F. GensiniVolume:
19
Year:
2009
Language:
english
DOI:
10.1016/s0939-4753(09)70005-5
File:
PDF, 109 KB
english, 2009